<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2004</study_start_year><condition>Neoplasm Metastasis</condition><condition>Chemotherapy</condition><condition>Liver Metastases</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Liver Neoplasms</condition><disease>Neoplasm Metastasis</disease><disease>Chemotherapy</disease><disease>Liver Metastases</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Liver Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2020119</full_dataset_link><location>France</location><study_start_month>4</study_start_month><keyword>Oxaliplatin</keyword><keyword>Folfirinox</keyword><keyword>Leucovorin</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Intensified Chemotherapy in CRC After Resection of Liver Metastases</name><description>Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.</description><dates><creation>2004-04-15</creation></dates><accession>2020119</accession><cross_references><ClinicalTrials___gov>NCT00208260</ClinicalTrials___gov></cross_references></HashMap>